Join our 20th anniversary celebrations by browsing through the journal’s milestone achievements and our specially commissioned Editorial collection.
Articles
-
-
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
-
Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3
-
Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study
-
Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up
-
Use of NSAIDs in treating patients with arthritis
-
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
-
Degeneration of the intervertebral disc
-
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence
-
A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin®for treatment of osteoarthritis of the knee
Editors-in-Chief
Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA
Trending articles
Click here to view which articles have been shared the most in the last month.
First Author Profiles
Meet this month's featured authors!
Aims and scope
Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Prognostic factors for progression of osteoarthritis of the hip: a systematic review
The hip is the third joint most commonly affected by osteoarthritis (OA) and with no therapeutic cure for hip OA, predicting which patients with hip OA are more likely to show disease progression is important for healthcare professionals.
In this systematic review, Teirlinck et al assess the existing evidence of patient, health, and diagnostic variables associated with the progression in patients with hip osteoarthritis.
Follow
Annual Journal Metrics
-
Speed
62 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
131 days from submission to acceptance
25 days from acceptance to publicationCitation Impact
4.103 - 2-year Impact Factor
4.686 - 5-year Impact Factor
1.297 - Source Normalized Impact per Paper (SNIP)
1.684 - SCImago Journal Rank (SJR)Usage
2,048,553 Downloads
1,356 Altmetric mentions
